Rare TP53 Mutations in Finnish Breast Cancer Families
Author Information
Author(s): Rapakko K, Allinen M, Syrjäkoski K, Vahteristo P, Huusko P, Vähäkangas K, Eerola H, Kainu T, Kallioniemi O-P, Nevanlinna H, Winqvist R
Primary Institution: University of Oulu/Oulu University Hospital, Oulu, Finland
Hypothesis
Are germline TP53 mutations present in Finnish breast cancer families?
Conclusion
The study found that TP53 mutations are rare and occur only at specific sites in families with hereditary breast cancer.
Supporting Evidence
- The study represents the largest survey of the entire protein-encoding portion of TP53.
- Mutations were only found at conserved domains in families meeting Li-Fraumeni criteria.
- TP53 mutations explain only a small fraction of hereditary breast cancer cases.
Takeaway
This study looked for specific gene changes in families with breast cancer and found that these changes are very uncommon.
Methodology
The study screened for germline TP53 mutations in Finnish BRCA1 and BRCA2 mutation-negative families.
Limitations
The study only focused on families meeting specific criteria and may not represent all breast cancer cases.
Participant Demographics
Finnish families with breast cancer, specifically those negative for BRCA1 and BRCA2 mutations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website